This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Costa, E.
Right arrow Articles by Toffano, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Costa, E.
Right arrow Articles by Toffano, G.

The British Journal of Psychiatry 133: 239-248 (1978)
© 1978 The Royal College of Psychiatrists

Molecular mechanisms mediating the action of diazepam on GABA receptors

E Costa, A Guidotti and G Toffano

Two types of crude synaptic membranes have been prepared which differ in their kinetic properties to bind 3H-GABA in a Na+-free medium. One type (B) has one type of receptor (affinity or KD about 0.2 micrometer), the other type (A) has two populations of receptors which have a high (0.16 micrometer) and a low ((.02 micrometer) KD for GABA binding. This difference is due to the presence of a selective endogenous inhibitor of the high affinity receptor for GABA, a thermostable protein of about 15,000 molecular weight. Inhibitor action is counteracted by diazepam (7 X 10(-7) M), competitively. Clonazepam is more active but chlordiazepoxide is less active than diazepam. Two enantiomers of a benzodiazepine were studied. One of them is endowed with anxiolytic activity and nullifies the action of the endogenous inhibitor on high affinity GABA binding, the other is devoid of anxiolytic activity and is inactive against the inhibitor. The endogenous protein inhibitor also competitively blocks the high affinity binding of 3H-diazepam to Type A membranes. It is concluded that the endogenous inhibitor and diazepam act on the same receptor; and suggested that the endogenous inhibitor may be the natural ligand for the brain receptors that bind benzodiazepines with high affinity.


This article has been cited by other articles:


Home page
 ScienceHome page
M Baraldi and Z. Zeneroli
Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid
Science, April 23, 1982; 216(4544): 427 - 429.
[Abstract] [PDF]

Home page
 ScienceHome page
J. Tallman, S. Paul, P Skolnick, and D. Gallager
Receptors for the age of anxiety: pharmacology of the benzodiazepines
Science, January 18, 1980; 207(4428): 274 - 281.
[Abstract] [PDF]